Vimarsana
Biggest News Aggregation in the World

Page 5 - Issue 2 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Issue 2. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Issue 2 Today - Breaking & Trending Today

What to Expect When Getting Pulled Over in a Weed-Legal Ohio - Vimarsana News

What to Expect When Getting Pulled Over in a Weed-Legal Ohio

A specific pen test is thought to be a dead giveaway that you're stoned, but Hamilton County deputies say there's a lot more to a single OVI stop.

Passing Issue 2 Doesn't Come With Automatic Expungement for Marijuana Offenses | Ohio News | Cincinnati - Vimarsana News

Passing Issue 2 Doesn't Come With Automatic Expungement for Marijuana Offenses | Ohio News | Cincinnati

The tax revenue from legalizing cannabis could address some criminal justice reform through the social equity and jobs program fund.

Economic Impact: Ohio Could Potentially See Millions More in Tax Revenue if Issue 2 Passes - Vimarsana News

Economic Impact: Ohio Could Potentially See Millions More in Tax Revenue if Issue 2 Passes

An Ohio State University study estimates the potential annual tax revenue from legalizing marijuana ranges from $276 million to $403 million in year five of an operational cannabis market.

Could Legalizing Marijuana Cause More Fatal Car Crashes in Ohio? - Vimarsana News

Could Legalizing Marijuana Cause More Fatal Car Crashes in Ohio?

‘It’s extraordinarily complicated”

Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine - Vimarsana News

Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine

MELBOURNE, Australia, Feb. 15, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)today announces the successful completion of its joint research project conducted with Heidelberg University Hospital (UKHD) under the Research Cooperation Agreement announced in February 2021.[1] The aim of this project was to create and validate a generator-based theranostic compound for urologic oncology targeting PSMA[2] and utilising the beta-emitting isotope rhenium-188 (188Re). The outcomes from the research project - which included a pre-clinical and first-in-human evaluation...